Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Curr Opin Cardiol ; 36(3): 340-351, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: covidwho-1132615

RESUMEN

PURPOSE OF REVIEW: Despite attention to racial disparities in outcomes for heart failure (HF) and other chronic diseases, progress against these inequities has been gradual at best. The disparities of COVID-19 and police brutality have highlighted the pervasiveness of systemic racism in health outcomes. Whether racial bias impacts patient access to advanced HF therapies is unclear. RECENT FINDINGS: As documented in other settings, racial bias appears to operate in HF providers' consideration of patients for advanced therapy. Multiple medical and psychosocial elements of the evaluation process are particularly vulnerable to bias. SUMMARY: Reducing gaps in access to advanced therapies will require commitments at multiple levels to reduce barriers to healthcare access, standardize clinical operations, research the determinants of patient success and increase diversity among providers and researchers. Progress is achievable but likely requires as disruptive and investment of immense resources as in the battle against COVID-19.


Asunto(s)
COVID-19 , Racismo , Accesibilidad a los Servicios de Salud , Humanos , SARS-CoV-2
2.
Gen Hosp Psychiatry ; 66: 1-8, 2020.
Artículo en Inglés | MEDLINE | ID: covidwho-599549

RESUMEN

OBJECTIVE: The mental health toll of COVID-19 on healthcare workers (HCW) is not yet fully described. We characterized distress, coping, and preferences for support among NYC HCWs during the COVID-19 pandemic. METHODS: This was a cross-sectional web survey of physicians, advanced practice providers, residents/fellows, and nurses, conducted during a peak of inpatient admissions for COVID-19 in NYC (April 9th-April 24th 2020) at a large medical center in NYC (n = 657). RESULTS: Positive screens for psychological symptoms were common; 57% for acute stress, 48% for depressive, and 33% for anxiety symptoms. For each, a higher percent of nurses/advanced practice providers screened positive vs. attending physicians, though housestaff's rates for acute stress and depression did not differ from either. Sixty-one percent of participants reported increased sense of meaning/purpose since the COVID-19 outbreak. Physical activity/exercise was the most common coping behavior (59%), and access to an individual therapist with online self-guided counseling (33%) garnered the most interest. CONCLUSIONS: NYC HCWs, especially nurses and advanced practice providers, are experiencing COVID-19-related psychological distress. Participants reported using empirically-supported coping behaviors, and endorsed indicators of resilience, but they also reported interest in additional wellness resources. Programs developed to mitigate stress among HCWs during the COVID-19 pandemic should integrate HCW preferences.


Asunto(s)
Adaptación Psicológica , Infecciones por Coronavirus/psicología , Personal de Salud/psicología , Prioridad del Paciente/psicología , Neumonía Viral/psicología , Distrés Psicológico , Trastornos de Estrés Traumático Agudo/psicología , Adulto , COVID-19 , Estudios Transversales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pandemias
3.
Circ Heart Fail ; 13(7): e007220, 2020 07.
Artículo en Inglés | MEDLINE | ID: covidwho-546317

RESUMEN

The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic with primary respiratory manifestations in those who are symptomatic. It has spread to >187 countries with a rapidly growing number of affected patients. Underlying cardiovascular disease is associated with more severe manifestations of COVID-19 and higher rates of mortality. COVID-19 can have both primary (arrhythmias, myocardial infarction, and myocarditis) and secondary (myocardial injury/biomarker elevation and heart failure) cardiac involvement. In severe cases, profound circulatory failure can result. This review discusses the presentation and management of patients with severe cardiac complications of COVID-19 disease, with an emphasis on a Heart-Lung team approach in patient management. Furthermore, it focuses on the use of and indications for acute mechanical circulatory support in cardiogenic and/or mixed shock.


Asunto(s)
Síndrome Coronario Agudo/terapia , Arritmias Cardíacas/terapia , Infecciones por Coronavirus/terapia , Insuficiencia Cardíaca/terapia , Miocarditis/terapia , Neumonía Viral/terapia , Síndrome Coronario Agudo/complicaciones , Antibacterianos/efectos adversos , Antivirales/uso terapéutico , Arritmias Cardíacas/inducido químicamente , Arritmias Cardíacas/complicaciones , Azitromicina/efectos adversos , Betacoronavirus , COVID-19 , Cardiotónicos/uso terapéutico , Enfermedad Crónica , Infecciones por Coronavirus/complicaciones , Síndrome de Liberación de Citoquinas/complicaciones , Síndrome de Liberación de Citoquinas/terapia , Inhibidores Enzimáticos/efectos adversos , Oxigenación por Membrana Extracorpórea , Insuficiencia Cardíaca/etiología , Corazón Auxiliar , Humanos , Hidroxicloroquina/efectos adversos , Contrapulsador Intraaórtico , Infarto del Miocardio/complicaciones , Infarto del Miocardio/terapia , Miocarditis/complicaciones , Pandemias , Intervención Coronaria Percutánea , Neumonía Viral/complicaciones , SARS-CoV-2 , Choque Cardiogénico/etiología , Choque Cardiogénico/terapia , Tromboembolia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA